🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Caroline E. McCoach

ORCID: 0000-0002-6060-6982
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial”.

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0800
N/A
3.5DataRank · unranked
140 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Dwight H. Owen, Byoung Chul Cho +16 more

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8
N/A
1.9DataRank · unranked
88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Characterization of the tumor microenvironment landscape and deep learning-guided prediction of prognosis in lung adenocarcinoma with bulk RNA sequencing data.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21025
N/A
0DataRank · unranked
0 citations

Wei Wu, Elizabeth A. Yu, Caroline E. McCoach, Robert C. Doebele, Trever G. Bivona +1 more

Systematic Identification of Balanced Transposition Polymorphisms in Saccharomyces cerevisiae

UNC Libraries(2020)10.17615/9941-5s71
N/A
0DataRank · unranked
0 citations

Jason D. Lieb, Caroline E. McCoach, Eric Ganko, Frederick G. Mann, Corbin D. Jones +5 more

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.01.1628
N/A
0DataRank · unranked
129 citations

Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda +11 more

A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.23.465573
N/A
0DataRank · unranked
18 citations

Celia Fernández-Méndez, Lauren Čech, Johnny Yu, Ismail M. Meraz, Victor Olivas +28 more

Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.02.004
N/A
0DataRank · unranked
57 citations

Christian Rolfo, Alexander Drilon, Mario E. Lacouture, Benjamin Besse, Kōichi Goto +10 more

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Science Translational Medicine(2022)10.1126/scitranslmed.abc7480
N/A
0DataRank · unranked
45 citations

Min Lu, Hazel X. Ang, Ryan S. Soderquist, Christine E. Eyler, Haley M. Hutchinson +12 more

Data from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.c.6530655.v1
N/A
0DataRank · unranked
0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.05.021
N/A
0DataRank · unranked
73 citations

Victoria M. Raymond, Richard B. Lanman, Jacqulyne Robichaux, Junqin He, Monique B. Nilsson +17 more

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

Nature Communications(2024)10.1038/s41467-024-47423-0
N/A
0DataRank · unranked
88 citations

Yu‐Ting Chou, Lauren Čech, Celia Fernández-Méndez, Johnny Yu, Victor Olivas +30 more

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.18.423280
N/A
0DataRank · unranked
19 citations

Deborah R. Caswell, Natalie I. Vokes, Emily K. Law, Wei Wu, William Hill +43 more